WEBTOON Entertainment Inc. (WBTN) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged WrongdoingsAugust 27, 2024 at 16:00 PM EDT
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of WEBTOON Entertainment Inc. (“Webtoon” or “the Company”) (NASDAQ: WBTN). Investors who purchased Webtoon securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/WBTN. Investigation Details On August 8, 2024, just six weeks after its initial public offering, Webtoon reported its second quarter 2024 financials. The Company’s revenue of $321 million fell short of analysts’ forecasts. Following this news, Webtoon stock dropped 38.1% on the same day. What's Next? If you are aware of any facts relating to this investigation or purchased Webtoon securities, you can assist this investigation by visiting the firm’s site: bgandg.com/WBTN. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660. There is No Cost to You We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Why Bronstein, Gewirtz & Grossman Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on businesswire.com: https://www.businesswire.com/news/home/20240827278827/en/ Contacts
Bronstein, Gewirtz & Grossman, LLC
More NewsView More
Western Digital’s Nasdaq-100 Entry Caps Its AI-Driven Comeback ↗
Today 11:16 EST
Via MarketBeat
Via MarketBeat
Via MarketBeat
Pfizer Adds to Its Big Bet on Weight Loss Drugs ↗
Today 7:03 EST
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|